Table 1.
Baseline characteristics of 45 sporadic CHG children (per subject).
| Characteristics | Median (P25, P75) | n (%) |
|---|---|---|
| Age (years) | 6 (5.00, 10.50) | |
| Tumor volume (cm3) | 26.02 (10.72, 43.50) | |
| IVA (level) | 4 (2, 6) | |
| LVA (level) | 4 (2, 7) | |
| Gender | ||
| Male | 28 (62.22) | |
| Female | 17 (37.78) | |
| Symptom | ||
| Bilateral vision impaired | 33 (73.33) | |
| Unilateral visual impaired | 11 (24.44) | |
| Nystagmus | 5 (11.11) | |
| Strabismus | 3 (6.67) | |
| ICH | 25 (55.56) | |
| Precocious puberty | 9 (20.00) | |
| Hemiparesis | 2 (4.44) | |
| Shunt | 12 (26.67) | |
| Surgical approach | ||
| Longitudinal fissure approach | 21 (46.67) | |
| Transcallosal interforniceal approach | 20 (44.44) | |
| Subtemporal approach | 4 (8.89) | |
| Resection extent | ||
| >70% | 12 (26.67) | |
| 50–70% | 11 (24.44) | |
| <50% | 22 (48.89) | |
| AT | ||
| RT | 29 (64.44) | |
| CT | 3 (6.67) | |
| RT + Oral temozolomide | 10 (22.22) | |
| Observation | 3 (6.67) | |
| Pathology | ||
| PA | 14 (31.11) | |
| PXA or PA/PMXA | 20 (44.44) | |
| Diffuse astrocytoma | 8 (17.78) | |
| Ganglioglioma | 2 (4.44) | |
| Anaplastic astrocytoma | 1 (2.22) | |
| Tumor recurrence | 1 (2.22) |
IVA, initial visual acuity; LVA, last visual acuity; ICH, intracranial hypertension; AT, adjuvant treatment; RT, radiotherapy; CT, chemotherapy; PA, pilocytic astrocytoma; PMXA, pilomyxoid astrocytoma.